OUR
SERVICES
OUR SERVICES
Development of drugs against BSL3 pathogen
Clinical trials for BSL3 pathogen
Neutralization test of serum samples
Evaluation of diagnostic reagents against BSL3 pathogen
ABOUT
BSL3
Introduction
The “BSL3 Research and Analysis Laboratory” is equipped with the most updated laboratory facility and instruments in the hope to provide immediate diagnosis in confronting novel infectious diseases. Our short-term goal is to provide accurate experimental data for evaluation of prophylactic/ therapeutic strategies and diagnosis methods against BSL-3 pathogens. Our long-term goal is to integrate a scientific team from basic researchers and clinical specialties, to cultivate talents specialized in life-threating infectious diseases, and to strengthen collaboration with national centers of disease control, which will help us to have a more immediate response to emerging infectious diseases to protect national health and maintain social economic development.
LATEST
NEWS
NEWS
2022.04.19
Drug Repurposing for the Identification of Compounds with Anti-SARS-CoV-2 Capability via Multiple Targets
This work is published on Pharmaceutics in January, 2022. It is a cooperation with Prof. Hsueh-Fen Juan from Department of Life Science and Institute of Molecular and Cellular Biology, NTU.
The BSL-3 Research and Analysis Laboratory helped to determine the EC50 of these selected compounds against authentic SARS-CoV-2 variants via plaque reduction assay.
2022.04.19
Neutralizing Monoclonal Antibodies Inhibit SARS-CoV-2 Infection through Blocking Membrane Fusion
This work is published on Microbiology Spectrum in March, 2022. It is a cooperation with Prof. Shih-Chung Chang from Department of Biochemical Science and Technology, NTU.
The BSL-3 Research and Analysis Laboratory helped to perform and analyze the neutralization ability of monoclonal antibodies against authentic SARS-CoV-2 variants.
2022.04.19
A siRNA targets and inhibits a broad range of SARS-CoV-2 infections including Delta variant
This work is published on EMBO Molecular Medicine in February, 2022. It is a cooperation with Prof. Pan-Chyr Yang from Department of Internal Medicine, National Taiwan University Hospital, and Oneness Biotech. Co., Ltd..
The BSL-3 Research and Analysis Laboratory helped to screen and confirm the efficiency of siRNA against authentic SARS-CoV-2 variants.
Pathogen Surveillance
& Talent Cultivation